Ann Calby Miller is Director of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 7,710 shares of INO, which is worth approximately $68,850. The most recent transaction as insider was on May 15, 2024, when has been sold 2,166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.71K
88.41% 3M change
88.41% 12M change
Total Value Held $68,850

Ann Calby Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
BUY
Exercise of conversion of derivative security
-
2,166 Added 21.93%
7,710 Common Stock
May 16 2023
BUY
Exercise of conversion of derivative security
-
19,000 Added 22.21%
66,534 Common Stock
May 13 2022
BUY
Exercise of conversion of derivative security
-
18,000 Added 27.47%
47,534 Common Stock
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
4,273 Added 12.64%
29,534 Common Stock
May 14 2021
BUY
Exercise of conversion of derivative security
-
8,700 Added 25.62%
25,261 Common Stock
Mar 21 2021
BUY
Exercise of conversion of derivative security
-
4,274 Added 20.51%
16,561 Common Stock

Also insider at

PBYI
PUMA BIOTECHNOLOGY, INC. Healthcare
ALNA
Allena Pharmaceuticals, Inc. Healthcare
ACM

Ann Calby Miller

Director
Newton, MA

Track Institutional and Insider Activities on INO

Follow INOVIO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO